[go: up one dir, main page]

ES2138359T3 - Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales. - Google Patents

Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales.

Info

Publication number
ES2138359T3
ES2138359T3 ES96924834T ES96924834T ES2138359T3 ES 2138359 T3 ES2138359 T3 ES 2138359T3 ES 96924834 T ES96924834 T ES 96924834T ES 96924834 T ES96924834 T ES 96924834T ES 2138359 T3 ES2138359 T3 ES 2138359T3
Authority
ES
Spain
Prior art keywords
degradation
arterosclerous
dihydropyridine
therapy
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96924834T
Other languages
English (en)
Inventor
Abraham Sartani
Amedeo Leonardi
Rodolfo Testa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Application granted granted Critical
Publication of ES2138359T3 publication Critical patent/ES2138359T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE HA ENCONTRADO QUE LAS 1,4 - DIHIDROPIRIDINAS DETIENEN VARIOS PROCESOS QUE INTERVIENEN EN EL DESARROLLO DE LAS LESIONES VASCULARES ATEROSCLEROTICAS, COMO LA PROLIFERACION Y MIGRACION DE MIOCITOS, EL METABOLISMO DEL COLESTEROL EN LOS MACROFAGOS Y LA MODIFICACION OXIDATIVA DE LAS LIPOPROTEINAS DE BAJA DENSIDAD. POR TANTO, SON UTILES PARA LA FABRICACION DE MEDICAMENTOS QUE PREVENGAN, DETENGAN Y REVIERTAN LA DEGRADACION ATEROSCLEROTICA DE LAS PAREDES ARTERIALES HUMANAS. LAS 1,4 - DIHIDROPIRIDINAS PREFERENTES PARA ESTE PROPOSITO SON LERCANIDIPINO, (S) LERCANIDIPINO Y (R) - LERCANIDIPINO.
ES96924834T 1995-07-14 1996-06-28 Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales. Expired - Lifetime ES2138359T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Publications (1)

Publication Number Publication Date
ES2138359T3 true ES2138359T3 (es) 2000-01-01

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96924834T Expired - Lifetime ES2138359T3 (es) 1995-07-14 1996-06-28 Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales.

Country Status (19)

Country Link
EP (1) EP0839036B1 (es)
JP (1) JPH11509214A (es)
KR (1) KR19990028741A (es)
CN (1) CN1190345A (es)
AT (1) ATE183644T1 (es)
AU (1) AU690471B2 (es)
CA (1) CA2219501A1 (es)
CZ (1) CZ11698A3 (es)
DE (1) DE69603968T2 (es)
DK (1) DK0839036T3 (es)
ES (1) ES2138359T3 (es)
GR (1) GR3031096T3 (es)
HU (1) HUP9802736A3 (es)
IL (1) IL122302A (es)
IT (1) IT1275532B (es)
NO (1) NO980171D0 (es)
SK (1) SK4198A3 (es)
WO (1) WO1997003669A1 (es)
ZA (1) ZA965924B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
SI2585051T2 (sl) 2010-06-23 2020-07-31 Krka, D.D., Novo Mesto Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
HUE026295T2 (en) 2010-10-12 2016-06-28 The Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
EA023996B1 (ru) 2010-12-24 2016-08-31 КРКА, д.д., НОВО МЕСТО Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
CA2219501A1 (en) 1997-02-06
EP0839036A1 (en) 1998-05-06
WO1997003669A1 (en) 1997-02-06
CN1190345A (zh) 1998-08-12
IL122302A (en) 2000-08-13
GR3031096T3 (en) 1999-12-31
HUP9802736A3 (en) 2000-03-28
IL122302A0 (en) 1998-04-05
ITMI951513A0 (it) 1995-07-14
IT1275532B (it) 1997-08-07
AU690471B2 (en) 1998-04-23
EP0839036B1 (en) 1999-08-25
CZ11698A3 (cs) 1998-06-17
ATE183644T1 (de) 1999-09-15
NO980171L (no) 1998-01-14
DE69603968D1 (de) 1999-09-30
NO980171D0 (no) 1998-01-14
AU6516496A (en) 1997-02-18
DE69603968T2 (de) 2000-04-06
JPH11509214A (ja) 1999-08-17
ZA965924B (en) 1997-01-30
DK0839036T3 (da) 2000-01-24
KR19990028741A (ko) 1999-04-15
SK4198A3 (en) 1998-05-06
ITMI951513A1 (it) 1997-01-14
HUP9802736A2 (hu) 1999-03-29

Similar Documents

Publication Publication Date Title
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
FI104324B1 (fi) Menetelmä terapeuttisesti käyttökelpoisen, liukenemattoman, turpoavan polymeerisen allyyliammoniumjohdannaisen valmistamiseksi
NO972980L (no) Anvendelse av nebivolol som et anti-aterogent middel
CY1106602T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
ATE56021T1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
NO304795B1 (no) Tetrazolderivater av gallesyrer, legemidler inneholdende dem og deres anvendelse som legemiddel
PT91863A (pt) Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
MX9604434A (es) Productos farmaceuticos y medicamentos para la prevencion y el tratamiento de disfunciones endoteliales.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
DE69429806D1 (de) Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung
ES2138359T3 (es) Utilizacion de derivados de 1,4 dihidropiridina en la prevencion y la terapia de la degradacion arteroesclerosa de las paredes arteriales.
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
ES2066239T3 (es) Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen.
DE59107336D1 (de) Oligosaccharidderivate und deren Verwendung in Heilmitteln
AR004489A1 (es) Benzopiranos, su utilizacion para preparar medicamentos, las composiciones farmaceuticas que los contienen, los procedimientos para preparar dichos compuestos y compuestos intermediarios
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
DK113789A (da) Thiosulfinsyrederivater, deres anvendelse til behandling af betaendelsessygdomme samt laegemiddel indeholdende disse stoffer
DE69124380D1 (de) Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 839036

Country of ref document: ES